AACR Annual Meeting 2017 Poster

13, Apr 2017

Dr. Eskouhie Tchaparian, from our Preclinical & Development Division, participated in the AACR Annual Meeting 2017 on April 1 - 5, 2017 at Walter E. Washington Convention Center, Washington, D.C., USA.


Poster Abstract Number: #2126

Subject: CA102N, a Conjugate of Hyaluronic Acid (HA) and Nimuselide Derivative (H-Nim) Interferes with PI3K/Akt/mTOR Signaling Pathway In Colorectal Cancer (CRC) Cells and Inhibits Tumor Growth in vivo.”


  • We revealed that CA102N can target the PI3K/Akt/mTOR mediated pathways to inhibit tumor growth, angiogenesis and possibly induce autophagy.
  • CA102N treatment results in significant inhibition of tumor cell growth, both in vitro and in vivo.
  • Apoptosis induced by CA102N is established as a central mechanism of tumor suppression.
  • On the basis of these findings, CA102N is currently under development as a novel therapeutic candidate for the treatment of patients with colorectal cancer.

To see the poster, please click here.

For more information about the AACR Annual Meeting 2017, please visit

previous page